- Home
- OLB vs SCNI Comparison
OLB vs SCNI Comparison
Compare OLB & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLB
- SCNI
- Stock Information
- Founded
- OLB 1993
- SCNI 2003
- Country
- OLB United States
- SCNI Israel
- Employees
- OLB N/A
- SCNI N/A
- Industry
- OLB EDP Services
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OLB Technology
- SCNI Health Care
- Exchange
- OLB Nasdaq
- SCNI Nasdaq
- Market Cap
- OLB 2.3M
- SCNI 1.9M
- IPO Year
- OLB N/A
- SCNI N/A
- Fundamental
- Price
- OLB $2.26
- SCNI $2.55
- Analyst Decision
- OLB
- SCNI
- Analyst Count
- OLB 0
- SCNI 0
- Target Price
- OLB N/A
- SCNI N/A
- AVG Volume (30 Days)
- OLB 253.0K
- SCNI 1.1M
- Earning Date
- OLB 05-15-2025
- SCNI 07-01-2025
- Dividend Yield
- OLB N/A
- SCNI N/A
- EPS Growth
- OLB N/A
- SCNI N/A
- EPS
- OLB N/A
- SCNI N/A
- Revenue
- OLB $11,664,342.00
- SCNI $658,000.00
- Revenue This Year
- OLB N/A
- SCNI N/A
- Revenue Next Year
- OLB N/A
- SCNI N/A
- P/E Ratio
- OLB N/A
- SCNI N/A
- Revenue Growth
- OLB N/A
- SCNI N/A
- 52 Week Low
- OLB $1.00
- SCNI $1.90
- 52 Week High
- OLB $4.00
- SCNI $8.92
- Technical
- Relative Strength Index (RSI)
- OLB 78.36
- SCNI 46.70
- Support Level
- OLB $2.00
- SCNI $2.32
- Resistance Level
- OLB $2.50
- SCNI $6.18
- Average True Range (ATR)
- OLB 0.27
- SCNI 0.41
- MACD
- OLB 0.09
- SCNI -0.01
- Stochastic Oscillator
- OLB 80.80
- SCNI 8.10
About OLB The OLB Group Inc.
The OLB Group Inc is a diversified fintech e-commerce merchant services provider and Bitcoin crypto mining enterprise. It focuses on a suite of products in the merchant services marketplace and seeks to provide integrated business solutions to merchants throughout the United States. Along with its subsidiaries, the company offers a cloud-based business management platform that provides turnkey solutions for merchants to enable them to build and manage their retail businesses, whether online or at a brick-and-mortar location, payment processing solutions, payment gateway, virtual terminal with proprietary business management tools, and crowdfunding solutions. The Company has two business segments; Fintech Services which generates key revenue, and the Bitcoin Mining business segment.
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.